VIR-5500

Vir Biotechnology doses first patient in Phase I VIR-5500 trial

TatendaJuly 22, 2026July 22, 2026

July 22, 2026July 22, 2026

Vir Biotechnology has dosed the first patient in one of three expansion cohorts in its ongoing Phase I clinical trial of VIR-5500 for metastatic prostate...

VIR-5500

Vir Biotechnology doses first patient in Phase I VIR-5500 trial

Brain Organoids Mature for More Than Five Years

South African pharma giant wins big from weight-loss drugs

China to free Southern African countries from ‘Big Pharma,’ by assisting them to produce own medicine

Mounjaro leads South Africa’s $187 million weight-loss drug boom as Aspen prepares Ozempic rival

Prof. Kruger helps shape the first hypertension guidelines for Africa

Editor's Picks

Brain Organoids Mature for More Than Five Years

South African pharma giant wins big from weight-loss drugs

China to free Southern African countries from ‘Big Pharma,’ by assisting them to produce own medicine

Medical News

Brain Organoids Mature for More Than Five Years

China to free Southern African countries from ‘Big Pharma,’ by assisting them to produce own medicine

Mounjaro leads South Africa’s $187 million weight-loss drug boom as Aspen prepares Ozempic rival

MEDICAL BREAKTHROUGHS

Why strategy beats speed in introducing AI for healthcare

AI identifies key gene driving aging in blood stem cells

SHA reforms push hospitals into multimillion-shilling technology upgrades